Immunomodulation therapy for squamous cell carcinoma of the head and neck.

Abstract

The role of the immune system in the pathogenesis and treatment of cancer is currently a popular area of research. An underlying fundamental concept of cancer immunology is the supposition that tumor cells express antigens differently than normal cells, both qualitatively and quantitatively. Understanding tumor-host interactions may suggest opportunities to modify these relationships to obtain antitumor effects. There is growing evidence that the immune system plays an important role in the pathogenesis of squamous cell carcinoma of the head and neck (SCCHN). Based on this evidence, trials studying the therapeutic efficacy of biologic response modifiers (BRMs) have been undertaken. These trials have had variable success, but continued efforts incorporating newer cytokines are underway.

Statistics

050100'02'04'06'08'10'12'14'16
Citations per Year

99 Citations

Semantic Scholar estimates that this publication has 99 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Cortesina1993ImmunomodulationTF, title={Immunomodulation therapy for squamous cell carcinoma of the head and neck.}, author={Giorgio Cortesina and Antonella De Stefani and Marianna Sacchi and Stefano Rosso and Elena Galeazzi}, journal={Head & neck}, year={1993}, volume={15 3}, pages={266-70} }